Skip to content
The Intraday
Pulse

Briefings

Morning BriefOvernight tape and the setup for the openMid-Morning UpdateWhat changed after the opening bell

Markets

Market DashboardTape, movers, watchlist, and cross-asset contextPre-Market SheetOvernight setup, futures, and early moversGlobal SessionsInternational clocks and index performanceInsider ActivityLatest reported executive transactions

AFL Research

Price ChartTechnical charting and drawing workspaceFundamentals ChartCompare financial metrics across timeCompany OverviewA visual snapshot of company performanceFinancial StatementsPrice, filings, key statistics, and news

Newsletter

Morning Production ReportRanked stories, charts, and newsletter readiness

Financial Statements

Explore

Markets, briefings, and company research

AFL
Pulse

Briefings

MorningMid-Morning

Markets

DashboardPre-MarketGlobalInsiders

AFL Research

ChartFundamentalsOverviewFinancials

Newsletter

Morning Report

Newsletter operations and account tools are available from your profile menu after sign-in.

Aflac Incorporated

AFL
$121.94
$-2.67 (-2.14%)-2.14%
Closed

Aflac Q2 2026: non-GAAP EPS $1.80 (+1% YoY), revenue $4.1B (-1% YoY), beats EPS and revenue estimates

Loading chart...
IndexN/A
Market Cap62.07B
Enterprise Value60.61B
Income$0.03B
Sales$3.45B
Employees12,694
P/E16.07
P/S3.35
P/B1.98
P/C22.88
EV/EBITDA10.97
EV/Sales12.75
EPS (ttm)7.59
Earnings2025-11-04
Gross Margin28.05%
Oper. Margin19.49%
Profit Margin34.20%
Volume3.43M
Shs Outstand0.51B
Change-2.14%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTD-0.66%
Perf Year2.84%
Perf 3Y51.17%
Perf 5Y132.75%
Perf 10Y287.65%
IPO1980-03-17
Income Statement by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Revenue$19.13B$18.84B$19.15B$21.55B$22.26B$22.24B$21.71B$21.60B
Cost of Revenue$12.31B$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Gross Profit$6.82B$18.84B$19.15B$21.55B$22.26B$22.24B$21.71B$21.60B
Gross Margin35.63%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Expenses$398.00M$13.58B$14.28B$16.34B$18.10B$17.80B$17.73B$17.58B
Operating Income$6.42B$5.26B$4.87B$5.21B$4.16B$4.45B$3.98B$4.02B
Operating Margin33.55%27.93%25.42%24.17%18.68%19.99%18.35%18.60%
Net Income$5.44B$4.66B$4.42B$4.23B$4.78B$3.30B$2.92B$4.60B
Net Margin28.46%24.73%23.07%19.64%21.46%14.86%13.45%21.31%
EPS (Basic)$9.68$7.81$6.96$6.42$6.69$4.45$3.79$5.52
EBITDA$6.42B$5.26B$4.87B$5.21B$4.16B$4.45B$3.98B$4.02B
Stock Option Compensation Expense$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Price To Earnings Ratio10.6010.5610.349.306.6411.8912.017.55
Price To Sales RatioN/AN/AN/AN/AN/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/AN/AN/AN/AN/A
Market Capitalization$57.71B$49.18B$45.67B$39.33B$31.74B$39.27B$35.06B$34.76B
Balance Sheet by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Cash & Short Term InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Short Term ReceivablesN/AN/AN/AN/AN/AN/AN/AN/A
InventoriesN/AN/AN/AN/AN/AN/AN/AN/A
Other Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Net Property, Plant & EquipmentN/AN/AN/AN/AN/AN/AN/AN/A
Total Investments and AdvancesN/AN/AN/AN/AN/AN/AN/AN/A
Long-Term Note ReceivableN/AN/AN/AN/AN/AN/AN/AN/A
Intangible AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Other AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Assets$117.57B$126.72B$131.74B$157.54B$165.09B$152.77B$140.41B$137.22B
Short Term Debt Incl. Current Port. of LT DebtN/AN/AN/AN/AN/AN/AN/AN/A
Accounts PayableN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax PayableN/AN/AN/AN/AN/AN/AN/AN/A
Other Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Provision for Risks ChargesN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Other LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$91.47B$104.74B$111.60B$124.29B$131.53B$123.81B$116.94B$112.62B
Non-Equity ReservesN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Stock - Carrying ValueN/AN/AN/AN/AN/AN/AN/AN/A
Common EquityN/AN/AN/AN/AN/AN/AN/AN/A
Total Shareholders Equity$26.10B$21.98B$20.14B$33.25B$33.56B$28.96B$23.46B$24.36B
Accumulated Minority InterestN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$26.10B$21.98B$20.14B$33.25B$33.56B$28.96B$23.46B$24.36B
Total Liabilities & Stockholders Equity$117.57B$126.72B$131.74B$157.54B$165.09B$152.77B$140.41B$137.22B
Book Value Per Share$46.78$36.88$31.73$49.36$47.02$39.01$30.49$31.06
Tangible Book Value Per Share$30.61$36.88$31.73$49.36$47.02$39.01$30.49$31.06
Full-Time EmployeesN/AN/AN/AN/AN/AN/AN/AN/A
Price to Book RatioN/AN/AN/AN/AN/AN/AN/AN/A
Return on Assets4.63%3.68%3.35%2.69%2.89%2.16%2.08%3.36%
Return on Equity20.86%21.19%21.94%12.72%14.24%11.41%12.45%18.90%
Return on Invested CapitalN/AN/AN/AN/A2.52%2.16%2.08%2.93%
Quick Ratio0.000.000.000.000.000.000.00161.74
Current Ratio0.000.000.000.000.000.000.00161.74
Cash Flow by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Net Income$5.44B$4.66B$4.42B$4.23B$4.78B$3.30B$2.92B$4.60B
Depreciation$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Other Funds (Non Cash)N/AN/AN/AN/AN/AN/AN/AN/A
Funds from OperationsN/AN/AN/AN/AN/AN/AN/AN/A
Extraordinary ItemN/AN/AN/AN/AN/AN/AN/AN/A
Changes in Working CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Income Taxes PayableN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Operating Activities$2.71B$3.19B$3.88B$5.05B$5.96B$5.46B$6.01B$6.13B
Capital Expenditures$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Net Assets From AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Fixed Assets and BusinessesN/AN/AN/AN/AN/AN/AN/AN/A
Purchase or Sale of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Purchase of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Sale Or Maturity of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Other UsesN/AN/AN/AN/AN/AN/AN/AN/A
Other SourcesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Investing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Cash Dividends Paid$1.09B$966.00M$979.00M$855.00M$769.00M$771.00M$793.00M$661.00M
Change in Capital StockN/AN/AN/AN/AN/AN/AN/AN/A
Repurchase of Common Pref Stock$2.80B$2.80B$2.40B$2.30B$1.54B$1.63B$1.30B$1.35B
Sale of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Proceeds from Stock OptionsN/AN/AN/AN/AN/AN/AN/AN/A
Issuance or Reduction of Debt, NetN/AN/AN/AN/AN/AN/AN/AN/A
Change in Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Issuance of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Reduction of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Net Financing Active Other Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Other Financing Activities UsesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Financing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Exchange Rate EffectN/AN/AN/AN/AN/AN/AN/AN/A
Net Change in CashN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow$2.71B$3.19B$3.88B$5.05B$5.96B$5.46B$6.01B$6.13B
Preferred Dividends (Cash Flow)N/AN/AN/AN/AN/AN/AN/AN/A
Price to Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A

Company coverage

Latest news

20 stories
Aug 9 · 8:30AMAflac: Reliable Dividend Compounder, Premium Justified, But Meaningful Upside Unlikelyseekingalpha.com ↗Aug 7 · 5:05PMAflac Q2 Earnings Call Highlightsmarketbeat.com ↗Aug 7 · 1:24PMAflac Incorporated (AFL) Q2 2026 Earnings Call Transcriptseekingalpha.com ↗Aug 7 · 11:51AMAflac Misses Q2 EPS Estimates Despite Solid US Sales Growthzacks.com ↗Aug 6 · 7:01PMAflac (AFL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com ↗Aug 6 · 6:41PMAflac (AFL) Q2 Earnings Lag Estimateszacks.com ↗Aug 6 · 6:00PMInsurer Aflac misses quarterly profit estimates on stronger dollarreuters.com ↗Aug 6 · 4:05PMAflac Incorporated Announces Second Quarter 2026 Results, Declares Third Quarter Dividendprnewswire.com ↗
Show 12 more stories↓
Aug 4 · 8:00AM76% of Gen Z and 63% of millennials turn to AI for first line of primary healthcareprnewswire.com ↗Aug 3 · 1:25PMCan Better Japan Profitability Support Aflac's Q2 Earnings Beat?zacks.com ↗Aug 3 · 10:16AMInsights Into Aflac (AFL) Q2: Wall Street Projections for Key Metricszacks.com ↗Jul 30 · 11:01AMAflac (AFL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?zacks.com ↗Jul 23 · 8:30AMThese 4 Stocks Are Wall Street's Most Reliable Dividend Growers247wallst.com ↗Jul 21 · 10:15PMAflac Has Raised Its Dividend for 43 Straight Years. Here's the Catch Income Investors Need to Watch.fool.com ↗Jul 20 · 11:12PMJosh Brown names top dividend stocks to own in 2026invezz.com ↗Jul 13 · 9:00AMNiagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxiagurufocus.com ↗Jul 1 · 8:10AMThe 3 Best Dividend Aristocrats for 2026: The Halftime Scorecard247wallst.com ↗Jun 30 · 4:05PMAflac Incorporated to Release Second Quarter Results and CFO Video Update on August 6, 2026 and Host Webcast on August 7, 2026prnewswire.com ↗Jun 30 · 9:40AMDo Options Traders Know Something About Aflac Stock We Don't?zacks.com ↗Jun 29 · 11:00AMDesigner Rachel Zoe and Aflac make fashion statement to urge Americans to check for cancergurufocus.com ↗

Insider Trading

View All
Insider
Type
Shares
Price
Value
Date
MOSKOWITZ JOSEPH L
Sell
600
$124.10
$74K
Aug 10, 26
MOSKOWITZ JOSEPH L
Option
20.3K
$44.59
$905K
Jun 22, 26
Japan Post Holdings Co., Ltd.
Sell
23.4K
$116.57
$2.7M
Jun 22, 26
MOSKOWITZ JOSEPH L
Sell
12.4K
$116.54
$1.4M
Jun 22, 26
Japan Post Holdings Co., Ltd.
Sell
600
$116.06
$70K
Jun 18, 26

Company

CEO: Daniel Paul AmosEmployees: 12716www.aflac.com
About the company↓

Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.

Discover more

You may be interested in
V

Visa Inc

$361.32

↓ 0.33%
AMD

Advanced Micro Devices

$469.56

↓ 2.86%
INTC

Intel Corp

$97.52

↓ 4.06%
GOOGL

Alphabet Inc

$357.52

↑ 0.91%
ORCL

Oracle Corp

$151.04

↑ 2.73%
IBM

IBM Corp

$236.31

↓ 0.41%
DIS

Walt Disney Co

$103.19

↓ 1.63%
NVDA

NVIDIA Corp

$217.55

↓ 2.86%
JPM

JPMorgan Chase & Co

$359.79

↑ 0.63%
TSLA

Tesla Inc

$330.88

↑ 0.70%
CRM

Salesforce Inc

$197.51

↑ 2.47%
BAC

Bank of America Corp

$63.86

↑ 1.09%
The Intraday

© 2026 The Intraday. All rights reserved.

Market data may be delayedFor informational purposes onlyFMP · Massive · SEC

Why it moved over time

Catalyst history

3 entries
Aug 7, 2026
Earnings+0.33%

Aflac (AFL) missed Q2 profit estimates as a stronger dollar and softness in its Japan unit weighed on results, a clear earnings-driven catalyst for recent trading.

Key fact: Q2 EPS $1.75 vs Zacks consensus $1.77, with management citing a stronger dollar and weakness in Japan.

reuters.com: Insurer Aflac misses quarterly profit estimates on stronger dollar↗
Aug 6, 2026
Earnings+0.33%

Market focus is on Aflac's Aug. 6 Q2 earnings, with analysts expecting a likely beat as improved Japan benefit-to-premium ratios may offset pressure on premiums and investment income.

Key fact: Analysts expect Aflac to beat Q2 results on Aug. 6, helped by improved Japan benefit-to-premium ratios.

prnewswire.com: 76% of Gen Z and 63% of millennials turn to AI for first line of primary healthcare↗
Aug 5, 2026
Earnings-1.23%

Market attention is on Aflac's Aug. 6 Q2 earnings, with analysts expecting an earnings beat partly due to improved Japan benefit-to-premium ratios that could offset premium and investment income pressure.

Key fact: Q2 earnings report due Aug. 6; analysts expect a beat supported by improved Japan benefit-to-premium ratios.

prnewswire.com: 76% of Gen Z and 63% of millennials turn to AI for first line of primary healthcare↗